Joanna Fares

Title: Joanna Fares: Innovator in Antibody Drug Conjugates

Introduction

Joanna Fares is a prominent inventor based in Aix-en-Provence, France. She has made significant contributions to the field of cancer treatment through her innovative work on antibody drug conjugates (ADCs). Her research focuses on developing targeted therapies that can improve patient outcomes.

Latest Patents

Joanna Fares holds a patent for an antibody drug conjugate targeting Nectin 4, which comprises an exatecan payload. The patent details the use of Nectin-4 ADCs in pharmaceutical compositions and outlines methods for utilizing these ADCs in cancer treatment. This innovative approach aims to enhance the efficacy of cancer therapies.

Career Highlights

Throughout her career, Joanna has worked with notable organizations, including Eli Lilly and Company and Université d'Aix-Marseille. Her experience in these institutions has allowed her to advance her research and contribute to the development of new therapeutic strategies.

Collaborations

Joanna has collaborated with esteemed colleagues such as Jacobus Petrus Maria Elands and Guy Fournet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Joanna Fares is a trailblazer in the field of antibody drug conjugates, with a focus on targeted cancer therapies. Her work exemplifies the importance of innovation in medicine and highlights the potential for new treatments to improve patient care.